TransCode Therapeutics, Inc.TransCode Therapeutics, Inc.TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪3.52 M‬USD
−472.8744USD
‪−18.55 M‬USD
‪6.54 M‬
Beta (1Y)
0.65

About TransCode Therapeutics, Inc.

CEO
Thomas A. Fitzgerald
Headquarters
Boston
Employees (FY)
10
Founded
2016
ISIN
US89357L3033
FIGI
BBG00ZGYHV03
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RNAZ is 0.51 USD — it has decreased by 5.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange TransCode Therapeutics, Inc. stocks are traded under the ticker RNAZ.
TransCode Therapeutics, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for TransCode Therapeutics, Inc. has a max estimate of 3.00 USD and a min estimate of 3.00 USD.
RNAZ earnings for the last quarter are −67.20 USD whereas the estimation was −60.00 USD which accounts for −12.00% surprise. Estimated earnings for the next quarter are −10.80 USD. See more details about TransCode Therapeutics, Inc. earnings.
Yes, you can track TransCode Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, RNAZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TransCode Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
RNAZ reached its all-time high on Jul 9, 2021 with the price of 5600.00 USD, and its all-time low was 0.56 USD and was reached on Feb 6, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 17, 2024, the company has 10.00 employees. See our rating of the largest employees — is TransCode Therapeutics, Inc. on this list?